[1]
|
D. Bornekamp, K. M. Horton, R. H. Hruban and E. K. Fishman, “Castleman Disease: The Great Mimic,” RadioGraphics, Vol. 31, No. 6, 2011, pp. 1793-1807.
doi:10.1148/rg.316115502
|
[2]
|
J. Herrada, F. Cabanillas, L. Rice, et al., “The Clinical Behavior of Localized and Multicentric Castleman Disease,” Annals of Internal Medicine, Vol. 128, No. 8, 1998, pp. 657-662.
|
[3]
|
T. W. Muskardin, B. A. Peterson and J. A. Molitor, “Castleman Disease and Associated Autoimmune Disease,” Current Opinion in Rheumatology, Vol. 24, No. 1, 2012, pp. 76-83. doi:10.1097/BOR.0b013e32834db525
|
[4]
|
S. P. Reynold, A. R. Gibbs, R. Weeks, et al., “Massive Pleural Effusion: An Unusual Presentation of Castleman’s Disease,” European Respiratory Journal, Vol. 5, No. 9, 1992, pp. 1150-1153.
|
[5]
|
H. E. El-Osta and R. Kurzrock, “Castleman’s Disease: From Basic Mechanism to Molecular Therapeutics,” The Oncologist, Vol. 16, 2011, pp. 497-511.
doi:10.1634/theoncologist.2010-0212
|
[6]
|
B. Roca, “Castleman’s Disease. A Review,” AIDS Reviews, Vol. 11, 2009, pp. 3-7.
|
[7]
|
K. Yoshizaki, T. Matsuda, N. Nishimoto, et al., “Pathogenic Significance of Interleukin-6 (IL-6/BSF-2) in Castleman’s Disease,” Blood, Vol. 74, No. 4, 1989, pp. 1360-1367.
|
[8]
|
I. S. Abdul-Rahman, A. M. Al-Amri and K. Q. Ghallab, “Castleman’s Disease: A Study of a Rare Lymphoproliferative Disorder in a University Hospital,” Clinical Medicine: Blood Disorders, Vol. 2, 2009, pp. 5-19.
|
[9]
|
B. Bandera, C. Ainsworth, J. Shikle, E. Rupard and M. Roach, “Treatment of Unicentric Castleman Disease with Neoadjuvant Rituximab,” Chest, Vol. 138, No. 5, 2009, pp. 1239-1241. doi:10.1378/chest.09-2084
|
[10]
|
A. Dham and B. A. Peterson, “Castleman Disease,” Current Opinion in Hematology, Vol. 14, No. 4, 2007, pp. 354-359. doi:10.1097/MOH.0b013e328186ffab
|
[11]
|
C. S. Restre-po, M. M. Chen, S. Martinez-Jimenez, J. Carrillo and C. Restrepo, “Chest Neoplasm with Infectious Etiologies,” World Journal of Radiology, Vol. 3, No. 12, 2011, pp. 279-288. doi:10.4329/wjr.v3.i12.279
|
[12]
|
C. H. Chen, H. C. Liu, T. T. Hung and T. P. Liu, “Possible Roles of Epstein-Barr Virus in Castleman Disease,” Journal of Cardiothoracic Surgery, Vol. 4, No. 31, 2009, pp. 1-5.
|
[13]
|
D. M. Cronin and R. A. Warnke, “Castleman Disease. An Update on Classification and the Spectrum of Associated Lesions,” Advances in Anatomic Pathology, Vol. 16, No. 4, 2009, pp. 236-246.
doi:10.1097/PAP.0b013e3181a9d4d3
|
[14]
|
H. J. Lach-mann, J. A. Gilbertson, J. D. Gillmore, P. N. Hawkins and M. B. Pepys, “Unicentric Castleman’s Disease Complicates by Systemic AA Amyloidosis: A Curable Disease,” International Journal of Medicine, Vol. 95, No. 4, 2002, pp. 211-218.
|
[15]
|
J. B. Alpert, D. Nonaka, A. Chachoua, et al., “Increasing Dyspnea Due to an Anterior Mediastinal Mass,” Chest, Vol. 139, No. 1, 2011, pp. 217-223.
doi:10.1378/chest.10-0383
|
[16]
|
B. F. Menezes, R. Mor-gan, M. Azad, “Multicentric Catleman’s Disease: A Case Report,” Journal of Medical Case Reports, Vol. 1, No. 78, pp. 2007.
|
[17]
|
S. F. Ko, M. J. Hseih, S. H. Ng, et al., “Imaging Spectrum of Castleman’s Disease,” American Journal of Roentgenology, Vol. 182, No. 3, 2004, pp. 769-775.
|
[18]
|
K. Enomoto, I. Nakamichi, K. Hamada, et al., ”Unicentric and Multicentric Castleman’s Disease,” British Journal of Radiology, Vol. 80, No. 949, 2007, pp. e24-e26.
doi:10.1259/bjr/93847196
|
[19]
|
S. D. Chang and R. F. Thoeni, “Castleman’s Disease Presenting as an Adnexal Mass: Ultrasound, CT and MRI Features,” British Journal of Radiology, Vol. 77, No. 914, 2004, pp. 161-163. doi:10.1259/bjr/30098414
|
[20]
|
K. Ohara, K. Narita, H. Ishikawa, et al., “Local Recurrence of Castleman Disease,” Kyobu Geka, Vol. 62, No. 2, 2009, pp. 136-139.
|
[21]
|
T. Ushio, K. Yoshimura and A. Kojima, “A Case of Castleman’s Disease That Recurred Nine Years after Initial Surgical Removal,” Nihon Kyobu Shikkan Gakkai Zasshi, Vol. 32, No. 12, 1994, pp. 1175-1180.
|
[22]
|
N. Yaris, M. Cakir, M. Kalyoncu, et al., “Castleman Disease: A Case with Atypical Presentation,” Pediatric Hematology Oncology, Vol. 21, 2004, pp. 203-208.
doi:10.1080/08880010490276908
|
[23]
|
H. Kurotaki, M. Kaimori and K. Nagai, “Recurred Castleman’s Disease Containing a Fibrohistiocytic Nodular Lesion with Vascular Occlusion,” Pathology International, Vol. 43, No. 10, 1993, pp. 603-607.
doi:10.1111/j.1440-1827.1993.tb03237.x
|
[24]
|
S. L. Han, X. X. Chen, X. F. Zheng, et al., “The Clinicopathological Behavior and Surgical Treatment of Abdominal Castleman’s Disease,” Singapore Medical Journal, Vol. 51, No. 10, 2010, pp. 813-816.
|
[25]
|
S. Shetty, R. A. Brenes, L. Panait and J. Sanchez, “Video Assisted Thoracoscopic Resection of a Posterior Mediastinal Castleman’s Tumor,” Journal of Cardiothoracic Surgery, Vol. 6, No. 113, 2011.
|
[26]
|
P. A. Seirafi, E. Ferguson and F. H. Edwards, “Thoracoscopic Resection of Castleman Disease, Case Report and Review,” Chest, Vol. 123, 2003, pp. 280-282.
doi:10.1378/chest.123.1.280
|
[27]
|
I. A. C. De Vries, M. M. S. van Acht, et al., “Neoadjuvant Radiotherapy of Primary Irresectable Unicentric Castleman’s Disease: A Case Report and Review of the Literature,” Radiation Oncology, Vol. 5, No. 7, 2010.
|
[28]
|
N. Talat and K. M. Schulte, “Castleman’s Disease: Systematic Analysis of 416 Patients from the Literature,” The Oncologist, Vol. 16, 2011, pp. 1316-1324.
doi:10.1634/theoncologist.2011-0075
|
[29]
|
P. Farruggia, A. Trizzino, N. Scibetta, et al., “Castleman’s Disease in Childhood: Report of Three Cases and Review of the Literature,” Italian Journal of Pediatrics, Vol. 35, No. 50, 2011.
|
[30]
|
N. S. Paramothayan and J. Barron, “New Criteria for the Differentiation between Transudates and Exudates,” Journal of Clinical Pathology, Vol. 55, No. 1, 2002, pp. 69-71. doi:10.1136/jcp.55.1.69
|
[31]
|
A. S. Leong, K. Cooper and F. J. Leong, “Manual of Diagnostic Cytology,” 2nd Edition, Greenwich Medical Media, Ltd., Cambridge, 2003, p. 29.
|
[32]
|
S. F. Ko, S. H. Ng, M. J. Hsieh, et al., “Castleman Disease of the Pleura: Expe-rience with Eight Surgically Proven Cases,” Annals of Thoracic Surgery, Vol. 76, No. 1, 2003, pp. 219-224.
doi:10.1016/S0003-4975(03)00133-4
|
[33]
|
J. O’Driscoll, “Giant Lymph Node Hyperplasia Presenting as a Pleural Mass,” Irish Medical Journal, Vol. 78, No. 5, 1985, pp. 132-133.
|
[34]
|
M. G. Alexandrakis, F. H. Passam, D. Ky-riakou and D. Bouros, “Pleural Effusions in Hematologic Malignancies,” Chest, Vol. 25, No. 4, 2004, pp. 1546-1555.
doi:10.1378/chest.125.4.1546
|
[35]
|
R. Burrah, V. Deshmane, S. Althaf, et al., “Castleman’s Disease of the Pleura,” General Thoracic and Cardiovascular Surgery, Vol. 59, No. 8, 2011, pp. 572-574.
doi:10.1007/s11748-010-0676-x
|
[36]
|
O. Ichiguchi and M. Yoshioka, “Castleman’s Disease in the Cardiophrenic Angle Resected Thoracoscopically; Report of a Case,” Kyobu Geka, Vol. 62, No. 2, 2009, pp. 161-163.
|